Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,506.00
(
0.28%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,503.38
(
0.18%
)
News Focus
News Focus
Post# of 257660
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123038
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 245992

Wednesday, 03/22/2023 1:46:42 PM

Wednesday, March 22, 2023 1:46:42 PM

Post# of 257660
TYK2 activity_heating_up—BHVN in-licenses candidate from China’s Hangzhou Highlightll Pharmaceutical:

https://finance.yahoo.com/news/biohaven-acquires-exclusive-license-oral-113000280.html

Note: The current BHVN is the residual offshoot of the company PFE acquired for $11.6B (#msg-168806558) minus the migraine portfolio.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today